Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817199-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 30, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
20,430
Total Value
$53,497.99
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 28,453 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 32,203 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 2,858 | $0.00 | $0.00 | 35,061 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Apr 30, 2026 | Sale | 3,214 | $16.65 | $53,497.99 | 31,847 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Apr 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Apr 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 15,000 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Apr 30, 2026 | Exercise/Conversion | 2,858 | $0.00 | $0.00 | 22,867 | Direct | โ | View Details |